# K02 implementation checkpoint: selected analyses and bound feedback

2 November 2026. The user asked to continue after the existing-evidence atlas. This unit implements two remaining components for the prospective lipid case and resolves a narrow target-coding question. **It runs no new biomedical generator, target analysis or complete campaign.**

## Decisions and actual changes

The [independent admission review](K02_ADMISSION_REVIEW_2026-11-02.md) confirmed literal F/M sex tokens through a code-only check of the existing, hash-verified file. No category frequencies, age values, outcomes or target effects were inspected. The [coordinator decision](K02_COORDINATOR_DECISION_2026-11-02.md) fixes the investigator-selected adult boundary and common valid subset and retains the three predeclared quantitative uses. General target-study context remains exposed, especially generic residual dependence; the case is not described as globally unseen.

The new [analysis component](analysis/README.md) accepts an explicitly supplied canonical DataFrame and computes the two adjusted BMI contrasts and residual TC/HDL correlation on the same rows. It preserves unavailable endpoints, reports eligibility exclusions and separates reference-only HC3 sensitivity intervals/normalization denominators from generated outputs. It is not a raw-data loader, access gate or full evaluator.

The new [supplemental feedback collector](operators/INTEGRATION.md) uses an already verified whole-cohort generator execution and a frozen evidence/context declaration. It explicitly calls or verifies semantic_feedback_v1; geometric-mean/prevalence diagnostics and any independently approved raw proxy differences are recorded separately. Unknown weighting remains unknown; geometric means stay unavailable in the strict v1 schema; no frame approval, source-SD conversion or exact-source certification is manufactured.

## Verification and limits of the verification

| Component | Actual verification | What it does not establish |
|---|---|---|
| K02 arithmetic | 17 new invented-array tests passed in 0.58 s. Independent raw-coordinate statsmodels calculations on a different 43-row fictional frame matched both slope/HC3 computations, residual correlation and reference SDs; exact differences are [recorded](analysis/INDEPENDENT_ARITHMETIC_CHECK.json). | No real target was prepared or fitted; no eligible reference N or generator quality result is available. |
| Supplemental collector | 37 new fixture tests passed in 1.52 s; after source-scale and typed-receipt review fixes, 11 affected tests passed, 32 deselected, in 1.10 s. Real v1 preflight/collection/recomputation and arithmetic were used; candidate/execution lifecycle verification was explicitly mocked. | This is adapter verification, not a WSL/sandbox or full end-to-end lifecycle run. No Agent-created clinical candidate was run. |
| Information and scientific scope | Independent source-context design and implementation review; original packet/engines and old campaign commitments checked unchanged. | Matching declarations and hashes do not authenticate extraction, source reconstruction, transport, authorship or absence of all unrecorded exposure. |

Independent reviews: [analysis](analysis/INDEPENDENT_REVIEW.md), [source-context design](SOURCE_CONTEXT_INTEGRATION_REVIEW_2026-11-02.md), and [collector implementation](EXECUTION_FEEDBACK_INDEPENDENT_REVIEW_2026-11-02.md). A failed initial pytest temporary-directory setup created no working fixture; the author used a fresh test-only location, documented in the integration note. Old passing suites were not rerun. No test artifacts or patient-level tables belong in the public export.

## What remains to reach an actual experiment

1. Freeze an Agent-visible source/task contract and the source/target context representation. Native source mmol/L and target mg/dL still need an explicit reviewed path. The historical ENS bridge is a design reference, not current strict-v1 orchestration.
2. Freeze common-model linkage and finite source-run budgets before executing source contexts. The new collector does not itself construct or compare the scientific source and target models. Derived non-HDL checks remain unsupported by its current task-column interface; no claim that all 30 Greiner numerical candidates are activated is made.
3. Complete the statistical reference, raw preparation, distribution diagnostics and evaluation-release/gate wiring under the existing campaign. The in-memory analysis function alone does not implement the case-level 0.10 resolution rule or authorize real-data access.
4. Continue remaining no-application cohort admission within the existing global-freeze rule. This unit does not shorten or enlarge the campaign by silently starting K02 alone.

These remaining items are concrete protocol/execution work. They do not require complete identification of every joint relationship, a new loss, model training, an additional Agent architecture or an unrelated benchmark. The Agent may make disclosed model/transport assumptions; actual analytical usefulness will be determined by the frozen real-reference evaluation.

## Accounting and stopping point

Candidate screening remains **3/6 families**, deep reading **3/12 originals**, measured saved-download bytes **232,810,156**, new case admissions/constructions/target evaluations **zero**. This unit downloaded nothing. Browser metadata traffic is unmetered. No source/target outcome table was emitted; only literal Sex category codes were newly observed.

The CHNS scheduler remains paused; no scheduled run was added. No frozen experiment, original source packet or old harness module was modified. The implementation checkpoint records the bounded work, preserves the remaining release gaps and returns to the existing prospective campaign. Clinical effect improvement is not claimed from passing software checks.
